Temasek Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$182M Sell
151,473
-21,786
-13% -$22.3M 0.49% 38
2026
Q1
$159M Buy
173,259
+55,412
+47% +$56.2M 0.52% 38
2025
Q4
$127M Sell
117,847
-23,819
-17% -$22.8M 0.4% 47
2025
Q3
$108M Buy
141,666
+32,405
+30% +$24.1M 0.37% 45
2025
Q2
$85.2M Buy
109,261
+13,571
+14% +$10.5M 0.33% 46
2025
Q1
$79M Buy
95,690
+25,390
+36% +$21.1M 0.32% 44
2024
Q4
$54.3M Hold
70,300
0.21% 44
2024
Q3
$62.3M Buy
70,300
+40,017
+132% +$36M 0.25% 43
2024
Q2
$27.4M Buy
+30,283
New +$24.2M 0.13% 63

Other funds holding LLY

Temasek Holdings's LLY Position: Q2 2026 in Review

Temasek Holdings reduced its Eli Lilly (LLY) stake by 13% in Q2 2026, selling an estimated $22.3M and leaving 151,473 shares worth $182M. The position accounts for 0.49% of the portfolio, ranked #38.

Temasek Holdings first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Temasek Holdings held 151,473 shares of Eli Lilly worth $182M as of Q2 2026.
  • Temasek Holdings sold 21,786 Eli Lilly shares in Q2 2026, an estimated $22.3M.
  • Eli Lilly made up 0.49% of Temasek Holdings's portfolio in Q2 2026, its #38 holding.
  • Temasek Holdings first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Temasek Holdings's 13F filing for Q2 2026, filed 7 Aug 2026.